Vascular Surgery, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Anesthesiology Department, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute, Milan, Italy.
J Endovasc Ther. 2021 Jun;28(3):425-433. doi: 10.1177/15266028211007459. Epub 2021 Apr 9.
TEVAR (thoracic endovascular aortic repair) + PETTICOAT (Provisional ExTension to Induce COmplete ATtachment) technique has been selectively employed since 2005 at our institution during endovascular treatment of type B aortic dissection (TBD). The aim of this study is to evaluate the long-term (>5 years) clinical results and the evolution of aortic volume.
All the patients receiving an endovascular treatment for TBD with the PETTICOAT technique were collected in a prospectively maintained database and follow-up computed tomography scan were retrospectively analyzed. Study endpoints included short- and long-term clinical success (absence of need for reintervention) and any major adverse event. The volumes of thoracic and abdominal aorta at long-term follow-up were also analyzed.
Twenty-eight patients received a TEVAR + PETTICOAT and were followed up (median follow-up 85 months). Primary 30-day clinical success rate was 82% with an adverse event rate of 31%; 4 type I endoleak and 1 retrograde dissection were recorded. Secondary mid-term clinical success was 96% while the long-term clinical success rate was 79%. Six cases (21%) received either an open repair or an endovascular repair for a significant distal aortic enlargement at follow-up. With regards to volumetric analysis, an increase of overall (thoracic and abdominal) aortic volume was observed in 8 cases mainly related to an increase (mean: +31%) of the abdominal volume that was observed in 11 cases.
PETTICOAT technique does not protect from long-term significant aneurysmal degeneration that may require aortic open or endovascular reinterventions. Aortic growth occurs mainly in the bare-stented aorta and thus, life-long surveillance is advisable in these patients.
自 2005 年以来,我们机构在腔内治疗 B 型主动脉夹层(TBD)时,选择性地采用了 TEVAR(胸主动脉腔内修复术)+PETTICOAT(临时扩展以诱导完全附着)技术。本研究旨在评估长期(>5 年)临床结果和主动脉体积的演变。
所有接受 PETTICOAT 技术腔内治疗 TBD 的患者均被收集在一个前瞻性维护的数据库中,并对回顾性分析了随访 CT 扫描。研究终点包括短期和长期临床成功(无再干预需求)和任何主要不良事件。还分析了长期随访时胸主动脉和腹主动脉的体积。
28 例患者接受了 TEVAR+PETTICOAT 治疗并进行了随访(中位随访时间 85 个月)。30 天的主要临床成功率为 82%,不良事件发生率为 31%;4 例 I 型内漏和 1 例逆行夹层。中期次要临床成功率为 96%,长期临床成功率为 79%。6 例(21%)在随访时因远端主动脉显著扩张而接受了开放修复或腔内修复。就体积分析而言,8 例患者的总(胸主动脉和腹主动脉)主动脉体积增加,主要与 11 例患者的腹主动脉体积增加(平均增加 31%)有关。
PETTICOAT 技术并不能防止长期的显著的瘤样变,这可能需要主动脉开放或腔内再干预。主动脉生长主要发生在裸支架的主动脉,因此这些患者需要终身监测。